IDEAS home Printed from https://ideas.repec.org/a/gam/jecomi/v10y2022i5p112-d813776.html

Aggregate Online Brand Name Pharmacy Price Dynamics for the United States and Mexico

Author

Listed:
  • Thomas M. Fullerton

    (Department of Economics & Finance, University of Texas at El Paso, El Paso, TX 79968-0543, USA)

  • Steven L. Fullerton

    (Border Region Modeling Project, University of Texas at El Paso, El Paso, TX 79968-0543, USA)

Abstract

Virtual cross-border medical tourism allows many residents in the United States to purchase brand name medicines from companies in Mexico without travelling there. Monthly economic reports indicate that the online brand name pharmaceutical product prices in Mexico are noticeably lower than the corresponding internet prices in the United States. There have been very few econometric studies on how these prices are linked and the dynamic nature of those relationships. Results in this study indicate that online medicine prices in Mexico respond very rapidly to online prices changes in the high-price market.

Suggested Citation

  • Thomas M. Fullerton & Steven L. Fullerton, 2022. "Aggregate Online Brand Name Pharmacy Price Dynamics for the United States and Mexico," Economies, MDPI, vol. 10(5), pages 1-5, May.
    • Handle: RePEc:gam:jecomi:v:10:y:2022:i:5:p:112-:d:813776
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2227-7099/10/5/112/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2227-7099/10/5/112/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Jr, Thomas M Fullerton & Pallares, Francisco J & Walke, Adam G, 2014. "Are Online Pharmacy Prices Really Lower in Mexico?," Asian Economic and Financial Review, Asian Economic and Social Society, vol. 4(4), pages 416-431.
    2. Francesca Barigozzi & Izabela Jelovac, 2020. "Research funding and price negotiation for new drugs," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 83-96, October.
    3. Sotiris Vandoros & Panos Kanavos, 2013. "The generics paradox revisited: empirical evidence from regulated markets," Applied Economics, Taylor & Francis Journals, vol. 45(22), pages 3230-3239, August.
    4. Francisco J. Pallares & Adam G. Walke & Thomas M., 2014. "Are Online Pharmacy Prices Really Lower in Mexico?," Asian Economic and Financial Review, Asian Economic and Social Society, vol. 4(4), pages 416-431, April.
    5. Rahmiye Figen Ceylan & Burhan Ozkan & Esra Mulazimogullari, 2020. "Historical evidence for economic effects of COVID-19," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(6), pages 817-823, August.
    6. Thomas M. Fullerton & Omar Solis, 2020. "Borderplex Bridge Wait Time Headache Reactions," Journal of Transport Economics and Policy, University of Bath, vol. 54(1), pages 58-5-78.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yoo, Sunbin & Managi, Shunsuke, 2020. "Global mortality benefits of COVID-19 action," Technological Forecasting and Social Change, Elsevier, vol. 160(C).
    2. Arvate, Paulo Roberto & Barbosa, Klênio & Gambardella, Dante, 2013. "Generic-branded drug competition and the price for pharmaceuticals in procurement auctions," Textos para discussão 333, FGV EESP - Escola de Economia de São Paulo, Fundação Getulio Vargas (Brazil).
    3. Hariharan, Vijay Ganesh & Landsman, Vardit & Stremersch, Stefan, 2024. "Branded response to generic entry: Detailing beyond the patent cliff," International Journal of Research in Marketing, Elsevier, vol. 41(3), pages 567-588.
    4. Kong Juan & Kepili Ema Izati Binti Zull, 2023. "A Survey Analysis: The Current Real Estate Marketing Situation in the China Greater Bay Area in the Context of the COVID-19 Epidemic," Real Estate Management and Valuation, Sciendo, vol. 31(3), pages 1-19, September.
    5. Michael Mueller & Alexander Frenzel, 2015. "Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 73-82, January.
    6. Rácz, Olivér Miklós, 2025. "Economic costs of distancing policy interventions," Economics & Human Biology, Elsevier, vol. 59(C).
    7. Gao Tianming & Vasilii Erokhin & Aleksandr Arskiy & Mikail Khudzhatov, 2021. "Has the COVID-19 Pandemic Affected Maritime Connectivity? An Estimation for China and the Polar Silk Road Countries," Sustainability, MDPI, vol. 13(6), pages 1-39, March.
    8. Antoine Tonnoir & Ioana Ciotir & Adrian-Liviu Scutariu & Octavian Dospinescu, 2021. "A Model for the Optimal Investment Strategy in the Context of Pandemic Regional Lockdown," Mathematics, MDPI, vol. 9(9), pages 1-12, May.
    9. Gigliotti, Marina & Rizzi, Francesco, 2023. "Resilient shopping behaviours by change, not by chance: are disruptive events’ effects permanent?," Journal of Retailing and Consumer Services, Elsevier, vol. 74(C).
    10. Castanheira, Micael & Ornaghi, Carmine & Siotis, Georges, 2019. "The unexpected consequences of generic entry," Journal of Health Economics, Elsevier, vol. 68(C).
    11. Bienvenido-Huertas, David, 2021. "Do unemployment benefits and economic aids to pay electricity bills remove the energy poverty risk of Spanish family units during lockdown? A study of COVID-19-induced lockdown," Energy Policy, Elsevier, vol. 150(C).
    12. Lin Lin & Bo Wang, 2025. "Marketing Status and Brand‐Name Drug Prices: Evidence From Rx‐To‐OTC Switch," Health Economics, John Wiley & Sons, Ltd., vol. 34(6), pages 1064-1084, June.
    13. Donatella Saccone, 2021. "Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(7), pages 1025-1038, September.
    14. Thiago Christiano Silva & Sergio Rubens Stancato de Souza & Solange Maria Guerra, 2021. "COVID-19 and Local Market Power in Credit Markets," Working Papers Series 558, Central Bank of Brazil, Research Department.
    15. Barja, Gover, 2021. "Using mobility measures to explain short-run economic performance during COVID-19's first wave," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 25(53), pages 4-20.
    16. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    17. Allen Bellas & Lea-Rachel Kosnik, 2023. "The Local and Aggregated Impacts of Stay-at-Home Orders on State Level Unemployment Outcomes," Eastern Economic Journal, Palgrave Macmillan;Eastern Economic Association, vol. 49(2), pages 142-155, April.
    18. Vikkram Singh & Homayoun Shirazi & Jessica Turetken, 2022. "The COVID-19 Era—Influencers of Uneven Sector Performance: A Canadian Perspective," Economies, MDPI, vol. 10(2), pages 1-24, February.
    19. Olivier Boiral & Marie-Christine Brotherton & Léo Rivaud & Laurence Guillaumie, 2021. "Organizations’ Management of the COVID-19 Pandemic: A Scoping Review of Business Articles," Sustainability, MDPI, vol. 13(7), pages 1-20, April.
    20. Jesús Marquina & María José Colinet & María del P. Pablo-Romero, 2021. "Measures to Promote Olive Grove Biomass in Spain and Andalusia: An Opportunity for Economic Recovery against COVID-19," Sustainability, MDPI, vol. 13(20), pages 1-33, October.

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jecomi:v:10:y:2022:i:5:p:112-:d:813776. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager The email address of this maintainer does not seem to be valid anymore. Please ask MDPI Indexing Manager to update the entry or send us the correct address (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.